Huijie Huang
Beijing, 100045, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Assessing the Value of Omalizumab for Pediatric Asthma in China: A Multicriteria Decision Analysis.
Journal: Healthcare (Basel, Switzerland)
Published: July 25, 2025
Cost-Effectiveness Analysis of Omalizumab Combined With Standard of Care in Treating Moderate to Severe Asthma Children in China.
Journal: Pediatric pulmonology
Published: August 25, 2024
The management of exercise-induced anaphylaxis in a Chinese child with biologics: a case report.
Journal: Frontiers in allergy
Published: June 24, 2024
Budesonide/formoterol maintenance and reliever therapy in childhood asthma: Real-world effectiveness and economic assessment.
Journal: Pediatric pulmonology
Published: March 20, 2023
Anaphylaxis in Chinese Children: Different Clinical Profile Between Children with and without a History of Asthma/Recurrent Wheezing.
Journal: Journal of asthma and allergy
Published: May 30, 2022
Anaphylaxis in Chinese Children with Pollen Sensitization: Triggers, Clinical Presentation, and Acute Management.
Journal: Journal of asthma and allergy
Published: February 18, 2022
Clinical Course and Factors Associated with Asthma Control in Children under Control-based Asthma Management: A Prospective Study.
Journal: Iranian journal of allergy, asthma, and immunology
Published: February 26, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026